These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37833526)

  • 1. Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
    Al-Ramahi JS; Shahzad M; Nguyen A; Li K; Amin MK; Ahmed N; Lutfi F; DeJarnette S; Chaudhary SG; Bansal R; Abdelhakim H; Shune L; Abdallah AO; Singh AK; Abhyankar SH; McGuirk JP; Mushtaq MU
    Bone Marrow Transplant; 2024 Jan; 59(1):134-137. PubMed ID: 37833526
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34
    Mohty R; Brissot E; Battipaglia G; Ruggeri A; Sestili S; Mediavilla C; Belhocine R; Dulery R; Mohty M; Malard F
    Curr Res Transl Med; 2019 Aug; 67(3):112-114. PubMed ID: 30591374
    [No Abstract]   [Full Text] [Related]  

  • 4. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
    Fraint E; Farooki S; Klein E; Mauguen A; Prockop SE; Scaradavou A; Curran K; Cancio M; Spitzer B; Boelens JJ; Oved J; Harris A; O'Reilly RJ; Kernan NA
    Transplant Cell Ther; 2023 Jan; 29(1):46.e1-46.e6. PubMed ID: 36210027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.
    Klyuchnikov E; El-Cheikh J; Sputtek A; Lioznov M; Calmels B; Furst S; Chabannon C; Crocchiolo R; Lemarié C; Faucher C; Bacher U; Alchalby H; Stübig T; Wolschke C; Ayuk F; Reckhaus ML; Blaise D; Kröger N
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):382-6. PubMed ID: 24321747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of CD34(+) selected stem cells for the treatment of poor graft function after allogeneic stem cell transplantation].
    Fei XH; He JB; Cheng HY; Yin YM; Zhang WJ; Zhang SQ; Wang XC; Wang JB
    Zhonghua Xue Ye Xue Za Zhi; 2018 Oct; 39(10):828-832. PubMed ID: 30369204
    [No Abstract]   [Full Text] [Related]  

  • 7. CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.
    Rangarajan HG; Crowell SA; Towerman AS; Shenoy SS
    Bone Marrow Transplant; 2022 Oct; 57(10):1592-1594. PubMed ID: 35798858
    [No Abstract]   [Full Text] [Related]  

  • 8. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
    Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fresh or Cryopreserved CD34
    Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
    Larocca A; Piaggio G; Podestà M; Pitto A; Bruno B; Di Grazia C; Gualandi F; Occhini D; Raiola AM; Dominietto A; Bregante S; Lamparelli T; Tedone E; Oneto R; Frassoni F; Van Lint MT; Pogliani E; Bacigalupo A
    Haematologica; 2006 Jul; 91(7):935-40. PubMed ID: 16818281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?
    Abboud R; Slade M; Abboud C; DiPersio JF
    Leuk Lymphoma; 2021 Mar; 62(3):749-751. PubMed ID: 33135522
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series.
    Ngwube A; Franay C; Shah N
    Pediatr Hematol Oncol; 2022 Aug; 39(5):475-480. PubMed ID: 35147476
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34
    Tamari R; Oran B; Hilden P; Maloy M; Kongtim P; Papadopoulos EB; Rondon G; Jakubowski AA; Andersson BS; Devlin SM; Ahmed S; Popat UR; Ponce D; Chen J; Sauter C; Young JW; de Lima M; Perales MA; O'Reilly RJ; Giralt SA; Champlin RE; Castro-Malaspina H
    Biol Blood Marrow Transplant; 2018 May; 24(5):1079-1087. PubMed ID: 29325829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34
    Mainardi C; Ebinger M; Enkel S; Feuchtinger T; Teltschik HM; Eyrich M; Schumm M; Rabsteyn A; Schlegel P; Seitz C; Schwarze CP; Müller I; Greil J; Bader P; Schlegel PG; Martin D; Holzer U; Döring M; Handgretinger R; Lang P
    Br J Haematol; 2018 Jan; 180(1):90-99. PubMed ID: 29205259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Transplant CD34
    Chandra S; Bleesing JJ; Jordan MB; Grimley MS; Khandelwal P; Davies SM; Edwards S; Leemhuis T; Marsh RA
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1527-1529. PubMed ID: 29555312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation.
    Sun YQ; Wang Y; Zhang XH; Xu LP; Liu KY; Yan CH; Liu ZY; Huang XJ
    Ann Hematol; 2019 Aug; 98(8):1877-1883. PubMed ID: 31144019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between CD34
    Yao D; Li B; Chu X; Pan J; Meng L; Hu Y; Gao L; Li J; Tian Y; Hu S
    Transpl Immunol; 2023 Apr; 77():101779. PubMed ID: 36596428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
    Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low CD34 and CD3 cell counts in the graft.
    Gower N; Coiteux V; Srour M; Magro L; Chauvet P; Terriou L; Varlet P; Ballot C; Yakoub-Agha I; Beauvais D
    Bone Marrow Transplant; 2022 Apr; 57(4):658-660. PubMed ID: 35087235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.